GAO Reissues Recommendations to Improve 340B Compliance, Medicare Financial Stability

GAO office building
The Government Accountability Office this month recommended that HHS and Congress take long-proposed actions to better ensure 340B program compliance and Medicare’s financial stability.
HHS and Congress should each take long-proposed actions—including a contentious action to curb certain Part B prescribing incentives—to better ensure [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Group Representing Large Community Health Centers Slams 340B Bill Endorsed by NACHC and PhRMA  

Advocates for Community Health wordmark
The health center advocacy group behind a proposed 340B program alternative recently slammed the 340B ACCESS Act, saying the newly introduced drug discount program overhaul bill would make it harder for members to leverage the 340B program and care for patients.
The health center advocacy group behind a proposed 340B program alternative recently slammed the 340B ACCESS Act, saying the newly [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Despite Unanimously Passing Senate, Rhode Island Fails to Pass Contract Pharmacy Protection Bill 

A state Senate-passed bill that would have prohibited 340B contract pharmacy restrictions in Rhode Island failed to clear the House before lawmakers in the Ocean State wrapped up their 2024 session last week.
A state Senate-endorsed bill that would have prohibited 340B contract pharmacy restrictions in Rhode Island failed to clear the legislature [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

In Stinging Op-Ed, West Virginia Senate Leader Bashes Drug Industry and Rejects Efforts to Politicize 340B Program

West Virginia Senate President Craig Blair (R), who also serves as the state’s lieutenant governor, told 340B Report that he’s weighing potential litigation against Stand for Us PAC, which has claimed credit for the GOP leader’s May 14 primary loss. (Photo courtesy: WV Senate.)
A key West Virginia lawmaker this week hit back against efforts to tie the 340B program to partisan politics, arguing [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Supreme Court to Review Case that Could Result in More Hospitals Qualifying for 340B Program

Supreme Court Justices announced in a June 10 order that they’d review the U.S. Court of Appeals for the D.C. Circuit’s September 2023 decision in Advocate Christ Medical Center v. Becerra.
The U.S. Supreme Court this week agreed to take on a case that potentially could expand the number of hospitals [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Bausch & Lomb Becomes 35th Manufacturer to Impose Contract Pharmacy Restrictions, Policy Applies to All 340B Entities

Canadian drug manufacturer Bausch & Lomb announced contract pharmacy restrictions that apply to all 340B covered entity types.
Canadian drugmaker Bausch & Lomb announced last week that, beginning July 1, it will no longer offer 340B discounted products [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Mount Sinai Reports 340B Pharmacy Revenue Losses in Early 2024

New York City-based Mount Sinai Hospital reported significantly decreased 340B pharmacy revenue at the start of 2024.
A major New York City hospital reported that decreased 340B pharmacy revenue helped drive millions in year-over-year losses in one [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

New York Unlikely to Move 340B Contract Pharmacy, PBM Protections Bill in 2024, Sponsors Say

New York lawmakers are expected to leave Albany this week without passing legislation that would bar drug manufacturers' and pharmacy benefit managers' (PBMs) policies against covered entities and N.Y. pharmacies based on their 340B participation.
New York lawmakers are expected to leave Albany this week without passing legislation that would bar drug manufacturers and pharmacy [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Sobi Becomes 34th Drugmaker to Implement Contract Pharmacy Restrictions, Exelixis Tightens Contract Pharmacy Policy

Exelixis wordmark building-mounted sign
California-based Exelixis, a specialty manufacturer with two high-priced drug products on the market, announced it is further restricting contract pharmacy access to 340B hospitals in a May 31 letter published on 340B ESP. 
Swedish biopharmaceutical company Sobi announced this week that beginning July 1 it will implement 340B contract pharmacy restrictions, making the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

OPA to Hold June 11 Webinar on Final ADR Rule

HRSA headquarters
The Health Resources and Services Administration announced that the Office of Pharmacy Affairs will hold a June 11 webinar on the ADR final rule.
The federal office tasked with overseeing the 340B program will brief covered entities and manufacturers next week on the administrative [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live